Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

IRIDEX Corporation - Common Stock (NQ:IRIX)

0.9776 -0.3724 (-27.59%)
Streaming Delayed Price Updated: 12:59 PM EDT, Mar 27, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about IRIDEX Corporation - Common Stock

< Previous 1 2 3 4 5 Next >
News headline image
Iridex: Q2 Earnings Insights ↗
Shares of Iridex (NASDAQ:IRIX) moved higher by 1.4% in after-market trading after the company reported Q2 results. Quarterly Results Earnings per share rose 145.00% over the past... 
Via Benzinga
News headline image
Return On Capital Employed Overview: Iridex ↗
In Q1, Iridex (NASDAQ:IRIX) posted sales of $11.96 million. Earnings were up 513.67%, but Iridex still reported an overall loss of $1.84 million. Iridex collected $12.30 million... 
Via Benzinga
News headline image
Recap: Iridex Q1 Earnings ↗
Shares of Iridex (NASDAQ:IRIX) were flat after the company reported Q1 results. Quarterly Results Earnings per share decreased 16.67% year over year to ($0.14), which were in... 
Via Benzinga
News headline image
Earnings Scheduled For May 11, 2021 ↗
Companies Reporting Before The Bell • Oxford Lane Capital (NASDAQ:OXLC) is estimated to report earnings for its fourth quarter. • ReWalk Robotics (NASDAQ:RWLK) is... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
Gainers Vaxart (NASDAQ:VXRT) shares moved upwards by 53.38% to $9.29 during Tuesday's regular session. Vaxart's stock is trading at a volume of 115.1 million... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
Gainers Reviva Pharmaceuticals (NASDAQ:RVPH) shares rose 72.91% to $7.47 during Monday's regular session. Reviva Pharmaceuticals's stock is trading at a volume of... 
Via Benzinga
News headline image
58 Biggest Movers From Yesterday ↗
Gainers Reviva Pharmaceuticals Holdings, Inc. (NASDAQ: RVPH) shares jumped 104.2% to close at $8.70 on Monday after the company announced the full details of its Phase 2 trial... 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.